Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 26Urinary Bladder Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 13Ovarian Neoplasms 10Nasopharyngeal Carcinoma 9Biliary Tract Neoplasms 8Non-Muscle Invasive Bladder Neoplasms 7Neoplasm Metastasis 7Cholangiocarcinoma 7Lymphoma, Large B-Cell, Diffuse 6Triple Negative Breast Neoplasms 5Colorectal Neoplasms 5Breast Neoplasms 5Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Carcinoma, Transitional Cell 4Osteosarcoma 3Melanoma 3Lymphoma, Non-Hodgkin 3Uterine Cervical Neoplasms 2Urologic Neoplasms 2Rectal Neoplasms 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Gallbladder Neoplasms 2Colonic Neoplasms 2

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1durvalumab 1Vinblastine 1Specimen Handling 1Platinum 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Pelvis and Ureter Urothelial Carcinoma × Gemcitabine × 30 days × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡